Table 6. Fracture risk categories in glucocorticoid-treated patients.

^a)https//www.shef.ac.uk/FRAX/tool.jsp. ^b)Increase the risk generated with FRAX by 1.15 for major osteoporotic fracture and 1.2 for hip fracture if GC treatment is .7.5 mg/day (i.e., if hip fracture risk is 2.0%, increase to 2.4%). ^c)Major osteoporotic fracture includes fractures of the spine (clinical), hip, wrist, or humerus.

FRAX, fracture-risk assessment tool; GC, glucocorticoid.

[Reprinted from “2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.”, by Buckley L, et al., 2017, Arthritis Care Res (Hoboken), 69, pp.1095–1110. Copyright 2017 by the Wiley. Reprinted with permission].